Meenal Kowshik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meenal Kowshik has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Priyanka Dwivedi
Department of Biological Sciences, Birla Institute of Technology and Science, Pilani-K.K Birla Goa Campus, Goa, 403726, India
1 shared publication- Vijayashree Nayak
Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, K.K. Birla Goa Campus, NH-17B, Zuarinagar, Goa, 403726, India
1 shared publication
Latest Publications
- 20 July 2015
- Published by Wiley in Biotechnology Progress
- Vol. 31 (5) , 1416-1422
Role of gold nanoparticles as drug delivery vehicles for chondroitin sulfate in the treatment of osteoarthritis
Osteoarthritis is a disease which is characterized by joint pain, swelling and stiffness. Articular cartilage has limited self‐repair capacity due to its avascular and aneural nature. In this work, we show the use of gold nanoparticles (AuNps) for enhancing the delivery of chondroitin sulfate (CS), a drug used in the treatment of osteoarthritis (OA). AuNps were synthesized and were characterized by transmission electron microscopy (TEM), ultraviolet‐visible (UV‐Vis) spectroscopy, Fourier transform infrared spectroscopy (FTIR), and X‐Ray diffraction analysis. AuNps were combined with CS (AuNps‐CS) and their effect on primary goat chondrocytes was studied using MTT assay, Hoechst staining, production of glycosaminoglycan and collagen. Cell viability studies by MTT revealed that AuNps‐CS stimulate cell proliferation. A two‐fold increase in GAG and collagen production was observed in presence of AuNps‐CS combination as compared to native CS, indicating that this combination stimulates chondrocyte proliferation and enhances extracellular matrix production (ECM). Hence, this study exhibits the potential of AuNps as a carrier of CS for treatment of osteoarthritis. © 2015 American Institute of Chemical Engineers Biotechnol. Prog. , 31:1416–1422, 2015
- 20 July 2015
- Published by Wiley in Biotechnology Progress
- Vol. 31 (5) , 1416-1422
Role of gold nanoparticles as drug delivery vehicles for chondroitin sulfate in the treatment of osteoarthritis
Osteoarthritis is a disease which is characterized by joint pain, swelling and stiffness. Articular cartilage has limited self‐repair capacity due to its avascular and aneural nature. In this work, we show the use of gold nanoparticles (AuNps) for enhancing the delivery of chondroitin sulfate (CS), a drug used in the treatment of osteoarthritis (OA). AuNps were synthesized and were characterized by transmission electron microscopy (TEM), ultraviolet‐visible (UV‐Vis) spectroscopy, Fourier transform infrared spectroscopy (FTIR), and X‐Ray diffraction analysis. AuNps were combined with CS (AuNps‐CS) and their effect on primary goat chondrocytes was studied using MTT assay, Hoechst staining, production of glycosaminoglycan and collagen. Cell viability studies by MTT revealed that AuNps‐CS stimulate cell proliferation. A two‐fold increase in GAG and collagen production was observed in presence of AuNps‐CS combination as compared to native CS, indicating that this combination stimulates chondrocyte proliferation and enhances extracellular matrix production (ECM). Hence, this study exhibits the potential of AuNps as a carrier of CS for treatment of osteoarthritis. © 2015 American Institute of Chemical Engineers Biotechnol. Prog. , 31:1416–1422, 2015